SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-23-000078
Filing Date
2023-08-03
Accepted
2023-08-03 16:01:05
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20230630.htm   iXBRL 10-Q 1295478
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112023-06.htm EX-31.1 9846
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122023-06.htm EX-31.2 9855
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212023-06.htm EX-32.1 7349
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222023-06.htm EX-32.2 7417
  Complete submission text file 0001610618-23-000078.txt   6045947

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20230630.xsd EX-101.SCH 40785
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20230630_cal.xml EX-101.CAL 49458
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20230630_def.xml EX-101.DEF 240976
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20230630_lab.xml EX-101.LAB 530899
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20230630_pre.xml EX-101.PRE 344888
55 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20230630_htm.xml XML 749991
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 231139720
SIC: 2836 Biological Products, (No Diagnostic Substances)